Pharmazz, Inc.   Report issue

For profit Phase 1 Phase 3
Founded: Willowbrook IL United States (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
2014
NCT02408731
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Chairman and CEO | Pharmazz, Inc.